These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 21592854)

  • 21. Rapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time reverse transcriptase PCR.
    Hindiyeh M; Ram D; Mandelboim M; Meningher T; Hirsh S; Robinov J; Levy V; Orzitzer S; Azar R; Grossman Z; Mendelson E
    J Clin Microbiol; 2010 May; 48(5):1884-7. PubMed ID: 20220153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
    Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
    Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy of an allele-specific reverse transcriptase-PCR assay targeting the H275Y oseltamivir resistant mutation in 2009 pandemic influenza A/H1N1 virus.
    Renaud C; Kuypers J; Corey L
    J Clin Virol; 2010 Sep; 49(1):21-5. PubMed ID: 20674476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of the h275y mutation in pandemic influenza A(H1N1) 2009 strains isolated in Malaysia.
    Suppiah J; Yusof MA; Othman KA; Saraswathy TS; Thayan R; Kasim FM; Murad S; Saat Z
    Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):100-4. PubMed ID: 21323171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.
    Huang W; Li X; Cheng Y; Tan M; Guo J; Wei H; Zhao X; Lan Y; Xiao N; Wang Z; Wang D; Shu Y
    Virol J; 2015 Jun; 12():96. PubMed ID: 26103966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay.
    Guo L; Garten RJ; Foust AS; Sessions WM; Okomo-Adhiambo M; Gubareva LV; Klimov AI; Xu X
    Antiviral Res; 2009 Apr; 82(1):29-33. PubMed ID: 19428592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
    Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
    Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation.
    Saito R; Sato I; Suzuki Y; Baranovich T; Matsuda R; Ishitani N; Dapat C; Dapat IC; Zaraket H; Oguma T; Suzuki H
    Pediatr Infect Dis J; 2010 Oct; 29(10):898-904. PubMed ID: 20442686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
    Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
    Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.
    Puzelli S; Facchini M; Di Martino A; Fabiani C; Lackenby A; Zambon M; Donatelli I
    Antiviral Res; 2011 Jun; 90(3):205-12. PubMed ID: 21514326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug-resistant influenza viruses: an overview].
    Hatakeyama S
    Nihon Rinsho; 2010 Sep; 68(9):1671-8. PubMed ID: 20845746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of intratreatment resistance to oseltamivir in pandemic influenza A H1N1 2009 virus.
    Valinotto LE; Diez RA; Barrero PR; Farías JA; López EL; Mistchenko AS
    Antivir Ther; 2010; 15(6):923-7. PubMed ID: 20834106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015.
    Tandel K; Sharma S; Dash PK; Parida M
    J Med Virol; 2018 May; 90(5):836-843. PubMed ID: 29288584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Y155H amino acid substitution in influenza A(H1N1)pdm09 viruses does not confer a phenotype of reduced susceptibility to neuraminidase inhibitors.
    Perez-Sautu U; Pozo F; Cuesta I; Monzon S; Calderon A; Gonzalez M; Molinero M; Lopez-Miragaya I; Rey S; Cañizares A; Rodriguez G; Gonzalez-Velasco C; Lackenby A; Casas I
    Euro Surveill; 2014 Jul; 19(27):14-20. PubMed ID: 25033052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.
    Correia V; Santos LA; Gíria M; Almeida-Santos MM; Rebelo-de-Andrade H
    J Med Virol; 2015 Jan; 87(1):45-56. PubMed ID: 25042157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oseltamivir-resistant influenza A(H1N1) 2009 virus in Greece during the post-pandemic 2010-2011 season.
    Kourti A; Spanakos G; Politi L; Stavropoulou A; Spanakis N; Tsakris A
    Int J Antimicrob Agents; 2012 Jul; 40(1):72-4. PubMed ID: 22591839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.
    Hurt AC; Ernest J; Deng YM; Iannello P; Besselaar TG; Birch C; Buchy P; Chittaganpitch M; Chiu SC; Dwyer D; Guigon A; Harrower B; Kei IP; Kok T; Lin C; McPhie K; Mohd A; Olveda R; Panayotou T; Rawlinson W; Scott L; Smith D; D'Souza H; Komadina N; Shaw R; Kelso A; Barr IG
    Antiviral Res; 2009 Jul; 83(1):90-3. PubMed ID: 19501261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixtures of oseltamivir-sensitive and -resistant pandemic influenza A/H1N1/2009 viruses in immunocompromised hospitalized children.
    Suhaila M; Tang JW; Lee HK; Lin C; Tambyah PA; Yap HK; Quak SH; Koay ES
    Pediatr Infect Dis J; 2011 Jul; 30(7):625-7. PubMed ID: 21206398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season.
    Zaraket H; Saito R; Wakim R; Tabet C; Medlej F; Reda M; Baranovich T; Suzuki Y; Dapat C; Caperig-Dapat I; Dbaibo GS; Suzuki H
    J Med Virol; 2010 Jul; 82(7):1224-8. PubMed ID: 20513088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.